Zealand Pharma A/S Cash Flow Quality Index
Zealand Pharma A/S cash flow quality index. Zealand Pharma A/S (ZEAL) has a Cash Flow Quality Index of 1.12x as of June 2025. Operating cash flow of Dkr8.52 Billion exceeds net income of Dkr7.57 Billion, indicating high earnings quality where cash backs reported profits. See how financially flexible is Zealand Pharma A/S to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zealand Pharma A/S (2011–2025)
Cash flow quality index of Zealand Pharma A/S from 2011 to 2025. Historical Cash Flow Quality Index for Zealand Pharma A/S across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Zealand Pharma A/S service its debt to assess how comfortably operating cash covers total debt obligations.
Zealand Pharma A/S Cash Flow Quality Index by Year (2011–2025)
Zealand Pharma A/S cash flow quality index by year from 2011 to 2025. Year-by-year earnings quality comparison for Zealand Pharma A/S. For the full cash flow conversion analysis, see how efficiently does Zealand Pharma A/S generate cash.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | Dkr6.53 Billion | Dkr6.46 Billion | ▲ +227.8% |
| 2018 | -0.79x | Dkr-460.40 Million | Dkr581.28 Million | ▼ -142.0% |
| 2012 | 1.88x | Dkr68.54 Million | Dkr36.37 Million | ▲ +1495.7% |
| 2011 | -0.14x | Dkr-1.81 Million | Dkr13.38 Million | — |